We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32B
AUM Growth
+$6.48B
Cap. Flow
+$4.77B
Cap. Flow %
14.9%
Top 10 Hldgs %
10.84%
Holding
2,554
New
720
Increased
686
Reduced
602
Closed
529

Sector Composition

Rank Sector Weight
1 Financials 20.47%
2 Consumer Discretionary 12.5%
3 Healthcare 10.55%
4 Industrials 6.63%
5 Real Estate 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVPT
1326
DELISTED
Travelport Worldwide Limited
TVPT
$1.02M ﹤0.01%
78,411
+55,513
+242% +$792K
FDX icon
1327
FedEx
FDX
$75.2B
$1.02M ﹤0.01%
+4,076
New +$932K
HBAN icon
1328
Huntington Bancshares
HBAN
$35.4B
$1.02M ﹤0.01%
69,832
-100,614
-59% -$1.41M
JKHY icon
1329
Jack Henry & Associates
JKHY
$11.1B
$1M ﹤0.01%
8,566
-1,634
-16% -$183K
OVV icon
1330
Ovintiv
OVV
$16.6B
$998K ﹤0.01%
14,980
-1,265
-8% -$74.6K
HPQ icon
1331
HP
HPQ
$27.2B
$997K ﹤0.01%
47,465
+7,541
+19% +$160K
QUOT
1332
DELISTED
Quotient Technology Inc
QUOT
$997K ﹤0.01%
84,845
-927,593
-92% -$12.9M
RY icon
1333
Royal Bank of Canada
RY
$293B
$995K ﹤0.01%
12,189
-10,272
-46% -$815K
PBH icon
1334
Prestige Consumer Healthcare
PBH
$2.61B
$989K ﹤0.01%
+22,269
New +$1.01M
MTUS icon
1335
Metallus
MTUS
$904M
$988K ﹤0.01%
65,012
-29,448
-31% -$448K
BUSE icon
1336
First Busey Corp
BUSE
$2.58B
$981K ﹤0.01%
32,752
+3,694
+13% +$115K
BRC icon
1337
Brady Corp
BRC
$4.61B
$978K ﹤0.01%
25,816
+3,373
+15% +$130K
KLAC icon
1338
KLA
KLAC
$258B
$977K ﹤0.01%
93,000
-10,000
-10% -$105K
ALNY icon
1339
Alnylam Pharmaceuticals
ALNY
$29B
$975K ﹤0.01%
+7,676
New +$965K
DORM icon
1340
Dorman Products
DORM
$4.12B
$974K ﹤0.01%
+15,934
New +$1.08M
WYNN icon
1341
Wynn Resorts
WYNN
$10.6B
$974K ﹤0.01%
5,779
-97,653
-94% -$15.1M
CRI icon
1342
Carter's
CRI
$1.47B
$972K ﹤0.01%
+8,274
New +$857K
DMK
1343
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$972K ﹤0.01%
3,157
+300
+11% +$98.7K
FLO icon
1344
Flowers Foods
FLO
$1.57B
$971K ﹤0.01%
50,279
+13,079
+35% +$251K
CSRA
1345
DELISTED
CSRA Inc.
CSRA
$971K ﹤0.01%
32,465
-1,835
-5% -$55.5K
DDS icon
1346
Dillards
DDS
$9.64B
$970K ﹤0.01%
+16,154
New +$895K
TRIP icon
1347
TripAdvisor
TRIP
$1.24B
$958K ﹤0.01%
+27,800
New +$1M
AAOI icon
1348
PUT
Applied Optoelectronics
AAOI
$11.1B
$946K ﹤0.01%
+25,000
New +$1.1M
BIG
1349
DELISTED
Big Lots, Inc.
BIG
$946K ﹤0.01%
+16,843
New +$913K
CBL
1350
DELISTED
CBL& Associates Properties, Inc.
CBL
$943K ﹤0.01%
+166,594
New +$1.11M

Similar funds

Balyasny Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Balyasny Asset Management held 2,554 positions worth $32B, up 25% from $25.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management deployed $4.77B of net new capital in Q4 2017, opening 720 new positions and adding to 686 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was American Express, an estimated $253M trimmed.

  • Balyasny Asset Management's largest Q4 2017 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
  • Balyasny Asset Management added most to Aetna Inc in Q4 2017, an estimated $175M increase.
  • Balyasny Asset Management's biggest Q4 2017 reduction was American Express, cutting an estimated $253M.
  • Balyasny Asset Management fully exited Range Resources in Q4 2017, selling an estimated $104M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $32B portfolio in Q4 2017.
  • Balyasny Asset Management opened 720 new positions and closed 529 in Q4 2017.
  • Balyasny Asset Management's portfolio value rose 25% quarter-over-quarter to $32B.

Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.